Literature DB >> 25327665

[The diagnosis and treatment guideline of Chinese patients with EGFR gene active mutation and ALK fusion gene-positive non-small cell lung cancer (2014 version)].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25327665

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN： 0253-3766


× No keyword cloud information.
  8 in total

Review 1.  China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version).

Authors:  Yuankai Shi; Yan Sun; Cuimin Ding; Ziping Wang; Changli Wang; Zheng Wang; Chong Bai; Chunxue Bai; Jifeng Feng; Xiaoqing Liu; Fang Li; Yue Yang; Yongqian Shu; Milu Wu; Jianxing He; Yiping Zhang; Shucai Zhang; Gongyan Chen; Honghe Luo; Rongcheng Luo; Caicun Zhou; Yanbin Zhou; Qingsong Pang; Hong Zhao; Qiong Zhao; Aiqin Gu; Yang Ling; Cheng Huang; Baohui Han; Shunchang Jiao; Hong Jiao
Journal:  Ann Transl Med       Date:  2015-10

Review 2.  China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version).

Authors:  Yuankai Shi; Yan Sun; Cuimin Ding; Ziping Wang; Changli Wang; Zheng Wang; Chong Bai; Chunxue Bai; Jifeng Feng; Xiaoqing Liu; Fang Li; Yue Yang; Yongqian Shu; Milu Wu; Jianxing He; Yiping Zhang; Shucai Zhang; Gongyan Chen; Honghe Luo; Rongcheng Luo; Caicun Zhou; Yanbin Zhou; Qingsong Pang; Hong Zhao; Qiong Zhao; Aiqin Gu; Yang Ling; Cheng Huang; Baohui Han; Shunchang Jiao; Hong Jiao
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 3.  [Diagnosis for ALK positive non-small cell lung cancer].

Authors:  Qin Feng; Xin Yang; Dongmei Lin
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-02

4.  [China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2015 version)].

Authors:  Yuankai Shi; Yan Sun; Cuimin Ding; Ziping Wang; Changli Wang; Zheng Wang; Chong Bai; Chunxue Bai; Jifeng Feng; Xiaoqing Liu; Fang Li; Yue Yang; Yongqian Shu; Milu Wu; Jianxing He; Yiping Zhang; Shucai Zhang; Gongyan Chen; Honghe Luo; Rongcheng Luo; Caicun Zhou; Yanbin Zhou; Qingsong Pang; Hong Zhao; Qiong Zhao; Aiqin Gu; Yang Ling; Cheng Huang; Baohui Han; Shunchang Jiao; Hong Jian
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-07

5.  Trends in Molecular Testing of Lung Cancer in Mainland People's Republic of China Over the Decade 2010 to 2019.

Authors:  Wenbin Li; Yunfeng Lyu; Shaoming Wang; Xiaoyan Zhou; Jie Ma; Chao Xu; Li Fang; Jianming Ying
Journal:  JTO Clin Res Rep       Date:  2021-03-11

6.  [China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment
(2016 version)].

Authors:  Yuankai Shi; Yan Sun; Cuimin Ding; Ziping Wang; Changli Wang; Chong Bai; Chunxue Bai; Jifeng Feng; Xiaoqing Liu; Fang Li; Yue Yang; Yongqian Shu; Milu Wu; Jianxing He; Yiping Zhang; Shucai Zhang; Gongyan Chen; Honghe Luo; Rongcheng Luo; Caicun Zhou; Qingsong Pang; Xingsheng Hu; Hong Zhao; Qiong Zhao; Aiqin Gu; Yang Ling; Cheng Huang; Baohui Han; Shunchang Jiao; Hong Jian
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-07-20

7.  [China Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)].

Authors:  Yuankai Shi; Yan Sun; Jinming Yu; Cuimin Ding; Ziping Wang; Changli Wang; Dong Wang; Cunde Wang; Zheng Wang; Mengzhao Wang; Xiuyi Zhi; You Lu; Jifeng Feng; Yunpeng Liu; Xiaoqing Liu; Wei Liu; Gang Wu; Xiaomei Li; Kai Li; Enxiao Li; Wei Li; Gongyan Chen; Zhengtang Chen; Ping Yu; Ning Wu; Milu Wu; Wenhua Xiao; Li Zhang; Yiping Zhang; Shucai Zhang; Shujun Yang; Xia Song; Dongmei Lin; Rongcheng Luo; Li Shan; Caicun Zhou; Zongmei Zhou; Qiong Zhao; Chengping Hu; Yi Hu; Qisen Guo; Jianhua Chang; Cheng Huang; Xuan Zeng; Baohui Han; Xiaohong Han; Bo Jia; Ying Han; Yu Huang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-01

8.  Cost-effectiveness analysis of dacomitinib versus gefitinib for the first-line therapy of patients with EGFR mutation-positive non-small-cell lung cancer in the United States and China.

Authors:  Xinglu Xu; Nan Fang; Huanan Li; Yanyan Liu; Fan Yang; Xin Li
Journal:  Ann Transl Med       Date:  2021-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.